少腹逐瘀汤加减联合西医疗法治疗子宫内膜异位症的Meta分析
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

首都卫生发展科研专项重点攻关项目(首发2018-1-4151)


Meta-analysis of Modified Shaofu Zhuyu Decoction Combined with Western Medicine in the Treatment of Endometriosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:对少腹逐瘀汤加减联合西医治疗子宫内膜异位症(Endometriosis,EMs)的有效性和安全性进行系统评价。方法:检索中国期刊全文数据库、中国学术期刊数据库、中文科技期刊数据库、CBM数据库、PubMed、The Cochrane Library、EMbase、Web of Science,选取有关少腹逐瘀汤加减联合西医治疗子宫内膜异位症的随机对照试验(RCT),检索时限为建库至2020年4月。运用RevMan5.3软件进行统计分析。结果:总共纳入11篇文献,包含1 003例患者。Meta分析结果显示:少腹逐瘀汤加减联合西医组较对照组可降低痛经视觉模拟评分法(VAS)评分及血清CA125水平,提高总有效率(RR=1.21,95%CI为1.15~1.28,P<0.000 01),缩减盆腔包块(MD=-1.06,95%CI为-1.59~-0.52,P=0.000 1)、降低LH水平(MD=-0.55,95%CI为-0.67~-0.43,P<0.000 01)及E2水平(MD=-15.23,95%CI为-17.15~-13.31,P<0.000 01),2组FSH水平及不良反应发生率差异无统计学意义。结论:少腹逐瘀汤加减联合西医疗法可有效提高总有效率,降低痛经VAS评分,缩小盆腔包块,降低LH、E2及血清CA125水平,且不增加不良反应发生率。但受纳入文献质量的限制,还需开展更多高质量、大规模的随机对照试验,为临床提供更强有力的循证医学证据。

    Abstract:

    To conduct a systematic review on efficacy and safety of Modified Shaofu Zhuyu Decoction combined with Western medicine in the treatment of endometriosis(EMs).Methods:The databases of WanFang Data,VIP,CNKI,CBM,PubMed,the Cochrane Library,EMbase and Web of Science were retrieved to gather randomized controlled trials(RCTs) on the efficacy of modified Shaofu Zhuyu Decoction combined with Western medicine in the treatment of endometriosis patients from the establishment of the database to April,2020.Meta-analysis was conducted with RevMan 5.3 software.Results:A total of 11 papers were retrieved with 1003 patients.Meta-analysis showed that,modified Shaofu Zhuyu Decoction combined with Western medicine group provided more reduction in the VAS score of dysmenorrhea and serum CA125,more improvement in the total effective rate[RR=1.21,95%CI(1.15 to 1.28),P<0.000 01 ]and more decrease in the size of pelvic mass[MD=-1.06,95%CI(-1.59 to -0.52),P=0.000 1],the level of LH[MD=-0.55,95%CI(-0.67 to -0.43),P<0.000 01] and E2[MD=-15.23,95%CI(-17.15 to -13.31),P<0.000 01].There were no significant difference in the level of FSH and the rate of adverse reactions between the 2 groups.Conclusion:Modified Shaofu Zhuyu Decoction combined with Western medicine can more effectively improve the total effective rate and reduce the VAS score of dysmenorrhea,the size of pelvic mass,the levels of LH and E2,and serum CA125 and do not increase the rate of adverse reactions.Because of the limited quality of the included papers,more high-quality,large-scale studies are needed to support clinic with evidence of evidence-based medicine.

    参考文献
    相似文献
    引证文献
引用本文

杨新春,鲍美如,时光,赵瑞华.少腹逐瘀汤加减联合西医疗法治疗子宫内膜异位症的Meta分析[J].世界中医药,2021,(23).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-05-13
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-01-05
  • 出版日期:
文章二维码